tiprankstipranks
Trending News
More News >
RegenXBio (RGNX)
NASDAQ:RGNX
US Market

RegenXBio (RGNX) Income Statement

Compare
992 Followers

RegenXBio Income Statement

Last quarter (Q3 2025), RegenXBio's total revenue was $29.73M, an increase of 22.88% from the same quarter last year. In Q3, RegenXBio's net income was $-61.94M. See RegenXBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 83.33M$ 90.24M$ 112.72M$ 470.35M$ 154.57M
Gross Profit
$ 49.76M$ 53.03M$ 58.18M$ 418.51M$ 118.85M
Operating Expenses
$ 283.11M$ 321.16M$ 321.06M$ 258.53M$ 238.09M
Depreciation and Amortization
$ 16.21M$ 17.32M$ 12.91M$ 9.56M$ 8.41M
EBITDA
$ -198.23M$ -239.46M$ -244.24M$ 169.54M$ -96.83M
Operating Income
$ -233.35M$ -268.13M$ -262.88M$ 159.98M$ -119.23M
Other Income/Expenses
$ 6.24M$ 4.48M$ -17.53M$ -18.73M$ 13.22M
Pretax Income
$ -227.10M$ -263.65M$ -280.40M$ 141.25M$ -106.01M
Net Income
$ -227.10M$ -263.49M$ -280.32M$ 127.84M$ -111.25M
Per Share Metrics
Basic EPS
$ -4.59$ -6.02$ -6.50$ 3.01$ -2.98
Diluted EPS
$ -4.59$ -6.02$ -6.50$ 2.91$ -2.98
Weighted Average Shares Outstanding
49.51M 43.73M 43.15M 42.44M 37.28M
Weighted Average Shares Outstanding (Diluted)
49.51M 43.73M 43.15M 43.91M 37.28M
Currency in USD

RegenXBio Earnings and Revenue History